Colgate-Palmolive (India) Limited (BOM:500830)
India
· Delayed Price · Currency is INR 2,458.45
-22.95 (-0.92%)
At close: Feb 21, 2025
Colgate-Palmolive (India) Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 60,677 | 56,804 | 52,262 | 50,998 | 48,412 | 45,251 | Upgrade
|
| Revenue Growth (YoY) | 9.50% | 8.69% | 2.48% | 5.34% | 6.99% | 1.40% | Upgrade
|
| Cost of Revenue | 18,956 | 17,727 | 18,438 | 17,138 | 15,912 | 16,121 | Upgrade
|
| Gross Profit | 41,721 | 39,077 | 33,824 | 33,860 | 32,500 | 29,130 | Upgrade
|
| Selling, General & Admin | 12,549 | 11,769 | 10,160 | 10,337 | 9,958 | 9,636 | Upgrade
|
| Other Operating Expenses | 9,220 | 8,271 | 8,160 | 7,821 | 7,347 | 7,294 | Upgrade
|
| Operating Expenses | 23,435 | 21,756 | 20,068 | 19,935 | 19,130 | 18,911 | Upgrade
|
| Operating Income | 18,286 | 17,321 | 13,756 | 13,925 | 13,370 | 10,219 | Upgrade
|
| Interest Expense | -45.96 | -49.96 | -49.14 | -58.95 | -72.59 | -96.16 | Upgrade
|
| Interest & Investment Income | 728.83 | 728.83 | 410.03 | 219.04 | 209.95 | 267.43 | Upgrade
|
| Currency Exchange Gain (Loss) | 3.73 | 3.73 | 26.44 | -12.19 | -16.03 | 14.86 | Upgrade
|
| Other Non Operating Income (Expenses) | 665.89 | 6.79 | 62.3 | 18.78 | 17.23 | 28.24 | Upgrade
|
| EBT Excluding Unusual Items | 19,638 | 18,011 | 14,206 | 14,092 | 13,509 | 10,433 | Upgrade
|
| Merger & Restructuring Charges | -0.02 | -195.02 | -112.09 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -2.5 | -2.5 | 3.13 | -1.64 | -6.85 | 0.21 | Upgrade
|
| Pretax Income | 19,636 | 17,813 | 14,097 | 14,090 | 13,502 | 10,434 | Upgrade
|
| Income Tax Expense | 5,019 | 4,577 | 3,625 | 3,307 | 3,148 | 2,269 | Upgrade
|
| Net Income | 14,616 | 13,237 | 10,471 | 10,783 | 10,354 | 8,165 | Upgrade
|
| Net Income to Common | 14,616 | 13,237 | 10,471 | 10,783 | 10,354 | 8,165 | Upgrade
|
| Net Income Growth | 16.00% | 26.41% | -2.89% | 4.15% | 26.81% | 5.27% | Upgrade
|
| Shares Outstanding (Basic) | 272 | 272 | 272 | 272 | 272 | 272 | Upgrade
|
| Shares Outstanding (Diluted) | 272 | 272 | 272 | 272 | 272 | 272 | Upgrade
|
| Shares Change (YoY) | 0.01% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | 53.74 | 48.67 | 38.50 | 39.65 | 38.07 | 30.02 | Upgrade
|
| EPS (Diluted) | 53.74 | 48.67 | 38.50 | 39.65 | 38.07 | 30.02 | Upgrade
|
| EPS Growth | 15.98% | 26.41% | -2.89% | 4.15% | 26.81% | 5.27% | Upgrade
|
| Free Cash Flow | - | 11,234 | 11,062 | 15,761 | 7,261 | 8,692 | Upgrade
|
| Free Cash Flow Per Share | - | 41.30 | 40.67 | 57.95 | 26.70 | 31.96 | Upgrade
|
| Dividend Per Share | 50.000 | 48.000 | 39.000 | 40.000 | 38.000 | 28.000 | Upgrade
|
| Dividend Growth | 16.28% | 23.08% | -2.50% | 5.26% | 35.71% | 86.67% | Upgrade
|
| Gross Margin | 68.76% | 68.79% | 64.72% | 66.39% | 67.13% | 64.37% | Upgrade
|
| Operating Margin | 30.14% | 30.49% | 26.32% | 27.31% | 27.62% | 22.58% | Upgrade
|
| Profit Margin | 24.09% | 23.30% | 20.04% | 21.14% | 21.39% | 18.04% | Upgrade
|
| Free Cash Flow Margin | - | 19.78% | 21.17% | 30.91% | 15.00% | 19.21% | Upgrade
|
| EBITDA | 19,790 | 18,844 | 15,302 | 15,470 | 14,977 | 11,838 | Upgrade
|
| EBITDA Margin | 32.62% | 33.17% | 29.28% | 30.33% | 30.94% | 26.16% | Upgrade
|
| D&A For EBITDA | 1,505 | 1,522 | 1,546 | 1,545 | 1,606 | 1,619 | Upgrade
|
| EBIT | 18,286 | 17,321 | 13,756 | 13,925 | 13,370 | 10,219 | Upgrade
|
| EBIT Margin | 30.14% | 30.49% | 26.32% | 27.31% | 27.62% | 22.58% | Upgrade
|
| Effective Tax Rate | 25.56% | 25.69% | 25.72% | 23.47% | 23.32% | 21.75% | Upgrade
|
| Revenue as Reported | 62,101 | 57,570 | 52,798 | 51,260 | 48,716 | 45,743 | Upgrade
|
| Advertising Expenses | - | 7,604 | 6,341 | 6,431 | 6,255 | 6,260 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.